Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites.
暂无分享,去创建一个
Harvey J Clewell | Weihsueh A Chiu | H. Clewell | W. Chiu | C. E. Hack | C Eric Hack | Q. Jay Zhao | Q Jay Zhao
[1] B C Allen,et al. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.
[2] Fredrik U. Jönsson,et al. Physiologically based pharmacokinetic modeling of inhalation exposure of humans to dichloromethane during moderate to heavy exercise. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[3] C Eric Hack,et al. Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models. , 2006, Toxicology.
[4] Harvey J Clewell,et al. Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice. , 2006, Regulatory toxicology and pharmacology : RTP.
[5] Harvey J Clewell,et al. A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment. , 2001, Environmental health perspectives.
[6] M. Templin,et al. Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. , 1993, Toxicology and applied pharmacology.
[7] F Y Bois,et al. Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics. , 2000, Environmental health perspectives.
[8] M S Prout,et al. Species differences in response to trichloroethylene. I. Pharmacokinetics in rats and mice. , 1985, Toxicology and applied pharmacology.
[9] H J Clewell,et al. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. , 2000, Environmental health perspectives.
[10] J W Fisher,et al. Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites. , 2000, Environmental health perspectives.
[11] J W Fisher,et al. In vitro to in vivo extrapolation for trichloroethylene metabolism in humans. , 1998, Toxicology and applied pharmacology.
[12] R. Tardif,et al. Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air , 1993, International archives of occupational and environmental health.
[13] R. Tardif,et al. Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air , 1995, International archives of occupational and environmental health.
[14] D. Henschler,et al. Metabolism of trichloroethylene in man , 2004, Archives of Toxicology.
[15] M E Andersen,et al. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse. , 1991, Toxicology and applied pharmacology.
[16] R. D. Stewart,et al. Experimental human exposure to trichloroethylene. , 1970, Archives of environmental health.
[17] M. Delp,et al. Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.
[18] F Y Bois,et al. Statistical issues in toxicokinetic modeling: a bayesian perspective. , 2000, Environmental health perspectives.
[19] Fredrik U. Jönsson,et al. Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene. , 2001, Toxicology.
[20] A. Gelman,et al. Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions , 1996 .
[21] Bradley P. Carlin,et al. BAYES AND EMPIRICAL BAYES METHODS FOR DATA ANALYSIS , 1996, Stat. Comput..
[22] Ulrike Bernauer,et al. Biotransformation of trichloroethene: dose-dependent excretion of 2,2,2-trichloro-metabolites and mercapturic acids in rats and humans after inhalation , 1996, Archives of Toxicology.
[23] D. Henschler,et al. Metabolism of trichloroethylene in man , 2004, Archives of Toxicology.
[24] A. Monster,et al. Kinetics of trichloroethylene in repeated exposure of volunteers , 1979, International archives of occupational and environmental health.
[25] J W Fisher,et al. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. , 1997, Toxicology and applied pharmacology.
[26] W. S. Snyder,et al. Report of the task group on reference man , 1979, Annals of the ICRP.
[27] Sylvia Richardson,et al. Inference and monitoring convergence , 1995 .
[28] P. Åstrand,et al. Textbook of Work Physiology , 1970 .
[29] F. A. Smith,et al. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.
[30] J W Fisher,et al. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. , 1998, Toxicology and applied pharmacology.
[31] P. Bonate,et al. Factors affecting species differences in the kinetics of metabolites of trichloroethylene. , 1995, Journal of toxicology and environmental health.
[32] J. Larson,et al. Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. , 1992, Toxicology and applied pharmacology.
[33] Sylvia Richardson,et al. Markov Chain Monte Carlo in Practice , 1997 .
[34] G. Johanson,et al. Physiologically based modeling of the inhalation kinetics of styrene in humans using a bayesian population approach. , 2002, Toxicology and applied pharmacology.
[35] T. Louis,et al. Bayes and Empirical Bayes Methods for Data Analysis. , 1997 .
[36] D. Henschler,et al. Trichloroethylene exposure and trichloroethylene metabolites in urine and blood , 2004, Archiv für Toxikologie.
[37] Jeffery M. Gearhart,et al. A Partition Coefficient Determination Method for Nonvolatile Chemicals in Biological Tissues , 1994 .